David Toung
Stock Analyst at Argus Research
(4.20)
# 516
Out of 4,412 analysts
76
Total ratings
65.12%
Success rate
8.09%
Average return
Main Sectors:
29 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Buy | $510 → $570 | $537.21 | +6.10% | 5 | Apr 10, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $80 → $110 | $76.24 | +44.28% | 1 | Apr 1, 2024 | |
| LH Laboratory Corporation of America Holdings | Upgrades: Buy | n/a | $201.37 | - | 1 | Mar 25, 2024 | |
| PFE Pfizer | Downgrades: Hold | n/a | $25.62 | - | 1 | Mar 22, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $290 | $229.00 | +26.64% | 2 | Mar 18, 2024 | |
| HUM Humana | Downgrades: Hold | n/a | $302.09 | - | 5 | Mar 13, 2024 | |
| CAH Cardinal Health | Upgrades: Buy | n/a | $103.04 | - | 4 | Feb 9, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $540 → $550 | $568.72 | -3.29% | 5 | Nov 6, 2023 | |
| AMGN Amgen | Maintains: Buy | $280 → $310 | $273.94 | +13.16% | 6 | Oct 17, 2023 | |
| LLY Eli Lilly | Maintains: Buy | $470 → $620 | $781.10 | -20.62% | 2 | Sep 5, 2023 | |
| CTLT Catalent | Upgrades: Buy | $62 | $55.85 | +11.01% | 2 | Sep 5, 2023 | |
| IART Integra LifeSciences Holdings | Downgrades: Hold | n/a | $29.17 | - | 1 | Jun 8, 2023 | |
| SYK Stryker | Maintains: Buy | $285 → $310 | $336.50 | -7.88% | 2 | May 25, 2023 | |
| SILK Silk Road Medical | Maintains: Buy | $70 → $55 | $19.44 | +182.92% | 3 | May 22, 2023 | |
| HCA HCA Healthcare | Maintains: Buy | $285 → $310 | $309.82 | +0.06% | 2 | May 10, 2023 | |
| ISRG Intuitive Surgical | Maintains: Buy | $265 → $320 | $370.62 | -13.66% | 3 | Dec 22, 2022 | |
| ABT Abbott Laboratories | Maintains: Buy | $150 → $135 | $105.97 | +27.39% | 3 | Jul 28, 2022 | |
| UNH UnitedHealth Group | Maintains: Buy | $580 → $650 | $483.70 | +34.38% | 4 | Jul 25, 2022 | |
| GILD Gilead Sciences | Upgrades: Buy | $75 | $65.20 | +15.03% | 3 | Jan 28, 2022 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Hold | n/a | $120.28 | - | 2 | Nov 23, 2021 | |
| BMY Bristol-Myers Squibb Company | Downgrades: Hold | n/a | $43.94 | - | 1 | Nov 1, 2021 | |
| MRK Merck & Co. | Upgrades: Buy | n/a | $129.22 | - | 3 | Nov 1, 2021 | |
| MDT Medtronic | Maintains: Buy | n/a | $80.24 | - | 4 | Aug 27, 2021 | |
| TDOC Teladoc Health | Downgrades: Hold | n/a | $12.75 | - | 1 | Aug 2, 2021 | |
| TECH Bio-Techne | Maintains: Buy | n/a | $63.21 | - | 2 | Jun 18, 2021 | |
| AZN AstraZeneca | Downgrades: Hold | n/a | $75.88 | - | 1 | Apr 12, 2021 | |
| NVS Novartis AG | Downgrades: Hold | n/a | $97.13 | - | 1 | Mar 10, 2021 | |
| ABBV AbbVie | Upgrades: Buy | n/a | $162.64 | - | 4 | Jun 2, 2020 | |
| JNJ Johnson & Johnson | Reiterates: Buy | n/a | $144.59 | - | 2 | Mar 27, 2020 |
McKesson
Apr 10, 2024
Maintains: Buy
Price Target: $510 → $570
Current: $537.21
Upside: +6.10%
GE HealthCare Technologies
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $76.24
Upside: +44.28%
Laboratory Corporation of America Holdings
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $201.37
Upside: -
Pfizer
Mar 22, 2024
Downgrades: Hold
Price Target: n/a
Current: $25.62
Upside: -
Charles River Laboratories International
Mar 18, 2024
Maintains: Buy
Price Target: $240 → $290
Current: $229.00
Upside: +26.64%
Humana
Mar 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $302.09
Upside: -
Cardinal Health
Feb 9, 2024
Upgrades: Buy
Price Target: n/a
Current: $103.04
Upside: -
Thermo Fisher
Nov 6, 2023
Maintains: Buy
Price Target: $540 → $550
Current: $568.72
Upside: -3.29%
Amgen
Oct 17, 2023
Maintains: Buy
Price Target: $280 → $310
Current: $273.94
Upside: +13.16%
Eli Lilly
Sep 5, 2023
Maintains: Buy
Price Target: $470 → $620
Current: $781.10
Upside: -20.62%
Catalent
Sep 5, 2023
Upgrades: Buy
Price Target: $62
Current: $55.85
Upside: +11.01%
Integra LifeSciences Holdings
Jun 8, 2023
Downgrades: Hold
Price Target: n/a
Current: $29.17
Upside: -
Stryker
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $336.50
Upside: -7.88%
Silk Road Medical
May 22, 2023
Maintains: Buy
Price Target: $70 → $55
Current: $19.44
Upside: +182.92%
HCA Healthcare
May 10, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $309.82
Upside: +0.06%
Intuitive Surgical
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $370.62
Upside: -13.66%
Abbott Laboratories
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $105.97
Upside: +27.39%
UnitedHealth Group
Jul 25, 2022
Maintains: Buy
Price Target: $580 → $650
Current: $483.70
Upside: +34.38%
Gilead Sciences
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $65.20
Upside: +15.03%
Zimmer Biomet Holdings
Nov 23, 2021
Downgrades: Hold
Price Target: n/a
Current: $120.28
Upside: -
Bristol-Myers Squibb Company
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $43.94
Upside: -
Merck & Co.
Nov 1, 2021
Upgrades: Buy
Price Target: n/a
Current: $129.22
Upside: -
Medtronic
Aug 27, 2021
Maintains: Buy
Price Target: n/a
Current: $80.24
Upside: -
Teladoc Health
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $12.75
Upside: -
Bio-Techne
Jun 18, 2021
Maintains: Buy
Price Target: n/a
Current: $63.21
Upside: -
AstraZeneca
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $75.88
Upside: -
Novartis AG
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $97.13
Upside: -
AbbVie
Jun 2, 2020
Upgrades: Buy
Price Target: n/a
Current: $162.64
Upside: -
Johnson & Johnson
Mar 27, 2020
Reiterates: Buy
Price Target: n/a
Current: $144.59
Upside: -